Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Hau, HM; Jahn, N; Brunotte, M; Wagner, T; Rademacher, S; Branzan, D; Sucher, E; Seehofer, D; Sucher, R.
Pre-operative ankle-brachial index for cardiovascular risk assessment in simultaneous pancreas-kidney transplant recipients: a simple and elegant strategy!
BMC Surg. 2021; 21(1):156
Doi: 10.1186/s12893-021-01159-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Hau Hans-Michael
- Jahn Nora
- Co-authors Med Uni Graz
- Sucher Robert
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Patients with insulin-dependent diabetes mellitus type 1 (IDDM1) and end-stage kidney disease (ESKD) undergoing simultaneous pancreas kidney transplantation (SPKT) are a population with diffuse atherosclerosis and elevated risk of cardio- and cerebrovascular morbidity and mortality. We aimed to investigate the feasibility of preoperative screening for peripheral arterial disease (PAD), specifically ankle-brachial index (ABI) testing, to predict peri- and postoperative outcomes in SPKT recipients. METHODS: Medical data (2000-2016) from all patients with IDDM and ESKD undergoing SPKT at our transplant center were retrospectively analyzed. The correlation between PAD (defined by an abnormal ABI before SPKT and graft failure and mortality rates as primary end points, and the occurrence of acute myocardial infarction, cerebrovascular and peripheral vascular complications as secondary end points were investigated after adjustment for known cardiovascular risk factors. RESULTS: Among 101 SPKT recipients in our transplant population who underwent structured physiological arterial studies, 17 patients (17%) were diagnosed with PAD before transplantation. PAD, as defined by a low ABI index, was an independent and significant predictor of death (HR, 2.99 (95% CI 1.00-8.87), p = 0.049) and pancreas graft failure (HR, 4.3 (95% CI 1.24-14.91), p = 0.022). No significant differences were observed for kidney graft failure (HR 1.85 (95% CI 0.76-4.50), p = 0.178). In terms of the secondary outcomes, patients with PAD were more likely to have myocardial infarction, stroke, limb ischemia, gangrene or amputation (HR, 2.90 (95% CI 1.19-7.04), p = 0.019). CONCLUSIONS: Pre-transplant screening for PAD and cardiovascular risk factors with non-invasive ABI testing may help to reduce perioperative complications in high-risk patients. Future research on long-term outcomes might provide more in depth insights in optimal treatment strategies for PAD among SPKT recipients.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult - administration & dosage
- Ankle Brachial Index - administration & dosage
- Female - administration & dosage
- Heart Disease Risk Factors - administration & dosage
- Humans - administration & dosage
- Kidney Transplantation - adverse effects
- Male - administration & dosage
- Mass Screening - methods
- Middle Aged - administration & dosage
- Pancreas Transplantation - adverse effects
- Peripheral Arterial Disease - diagnosis, epidemiology
- Preoperative Care - administration & dosage
- Retrospective Studies - administration & dosage
- Risk Assessment - methods
- Transplant Recipients - statistics & numerical data
- Treatment Outcome - administration & dosage
- Find related publications in this database (Keywords)
- Simultaneous pancreas kidney transplantation
- Graft outcome
- Patient outcome
- Ankle-brachial index
- Diabetes mellitus
- Peripheral arterial disease